Enhancing Doxorubicin Sensitivity in Osteosarcoma Cancer Cells: Unveiling the Role of Resveratrol-Induced Oxidative

Mohammad Reza Bazavar1, Hamed Helali1, Linda Mohammadzadeh Boukani2

  • 1Department of Orthopedic Surgery, School of Medicine and Shohada Educational Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.

Drug Research
|April 24, 2025
PubMed

Insights

Resveratrol enhances doxorubicin-induced apoptosis in Saos-2 cells by increasing DNA damage markers. This suggests Resveratrol may aid osteosarcoma treatment by boosting chemotherapy effects.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Doxorubicin (DOX) is a chemotherapy agent used to treat osteosarcoma.
  • DOX-induced DNA damage can lead to apoptosis in cancer cells.
  • Resveratrol (Resv) is a natural polyphenol with potential anti-cancer properties.

Purpose of the Study:

  • To investigate the effect of Resveratrol on doxorubicin-induced apoptosis in Saos-2 osteosarcoma cells.
  • To determine if Resveratrol influences DNA damage pathways activated by doxorubicin.

Main Methods:

  • Saos-2 cells were treated with DOX and Resveratrol.
  • Cell viability was assessed using MTT assay.
  • DNA damage markers (H2AX, ATR, ATM, Rad51, p53) were quantified by qRT-PCR and Western blotting.
  • Apoptosis was analyzed via flow cytometry.

Main Results:

  • Doxorubicin significantly suppressed Saos-2 cell proliferation in a dose-dependent manner.
  • Resveratrol enhanced DOX-induced apoptosis in Saos-2 cells (P<0.05).
  • Expression of DNA damage markers H2AX, ATR, ATM, Rad51, and p53 increased, potentially mediating apoptosis.

Conclusions:

  • Resveratrol potentiates doxorubicin-induced apoptosis in Saos-2 cells.
  • The findings suggest Resveratrol may enhance the efficacy of doxorubicin in osteosarcoma treatment.
  • Resveratrol's role in modulating DNA damage response pathways warrants further investigation for therapeutic applications.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.4K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K